Valye reports for unlimited access

Patriot National Bancorp, Inc. is a bank holding company headquartered in Connecticut, with its primary operating asset being Patriot Bank, N.A. The Bank operates eight branches in Connecticut and New York and a banking office in Beverly Hills, California. The company completed a substantial transformation in 2025 involving capital structure changes, management reconstitution, and strategic repositioning. The Bank operates under a Formal Agreement with the OCC requiring corrective actions in capital, governance, risk management, and compliance. Its business model focuses on relationship-driven banking and specialized financial services targeting entrepreneurs, investors, digital payments clients, and underbanked but creditworthy customers. Lending activities emphasize commercial real estate, high-net-worth credit facilities, and asset-backed financing. The Bank offers traditional deposit products and treasury management services, with institutional banking and digital payments as important sources of deposits and fee income. The company reported a net loss for 2025 and has increased liquidity and capital through private placements and registered offerings. The Bank faces regulatory scrutiny and operates in a competitive financial services environment.

CannaPharmaRX, Inc. is a cannabis production company with operations centered at its Cremona, Alberta facility. The company currently operates six of ten growing rooms and plans to open the remaining rooms within one to two years. It is actively expanding its presence in European markets, particularly Germany and Israel, and aims to obtain EU-GMP certification to facilitate direct shipments to EU countries. The company is managing significant debt obligations through negotiated payment schedules while focusing on growing its operations and product delivery.

Mainz Biomed N.V. develops and markets genetic diagnostic tests for early cancer detection, with a focus on colorectal and pancreatic cancers. The company was incorporated in 2021 and is headquartered in Mainz, Germany. It historically marketed ColoAlert, a CE-IVD certified colorectal cancer screening test in Europe, combining fecal immunochemical testing with PCR-based genetic marker analysis. Clinical studies demonstrated high sensitivity and specificity for colorectal cancer and advanced adenomas. In 2025, Mainz Biomed acquired exclusive rights to novel mRNA biomarkers and AI algorithms for non-invasive pancreatic cancer detection via blood tests and is developing PancAlert, a stool-based pancreatic cancer screening test. In early 2026, the company decided to discontinue ColoAlert and next-generation colorectal cancer product development, selling related intellectual property, and is shifting strategic focus toward post-quantum cybersecurity while continuing pancreatic cancer test development. The company reported a net loss of $16.2 million for fiscal 2025 and has implemented cost reductions including significant personnel cuts.

Vynleads, Inc. operates as a wellness technology company targeting metabolic health and chronic lifestyle-influenced conditions. Its primary product is the Done With Diabetes app, an eight-week structured program designed to support adults with type 2 diabetes and related conditions through lifestyle education, habit formation, and AI-enabled coaching. The platform integrates a proprietary personalization engine and an emerging agentic AI architecture to deliver daily missions, meal guidance, community features, and ongoing maintenance support. The company is shifting from one-time digital wellness products to a recurring subscription model priced at $29 per month, aiming to scale direct-to-consumer subscriptions and enterprise partnerships with employers, health plans, and payers. The platform is cloud-based and relies on third-party technology providers, with a small internal team. Vynleads faces competition from established digital health and wellness vendors and operates under various regulatory frameworks related to consumer protection, privacy, and AI use.

Smart Powerr Corp. is a Nevada-incorporated holding company conducting most of its business through subsidiaries in China. Historically a pioneer in waste energy recycling, the company uses a Build-Operate-Transfer model to provide energy saving and recovery facilities to energy-intensive industries. Its projects capture industrial waste energy to generate electricity, reducing energy costs and emissions for customers. The company is transitioning towards becoming an energy storage integrated solution provider, targeting new markets such as industrial complexes, renewable energy stations, remote islands, and smart energy cities. Operations are conducted through multiple wholly-owned subsidiaries in China. The company reported modest revenue and a net loss for the fiscal year ending 2025, with strong liquidity. It has not paid dividends and retains earnings for business operations and expansion. The company faces legal and operational risks related to PRC regulations and operates in a competitive market with risks from manufacturing dependencies and project execution delays [S1].

enCore Energy Corp. is a uranium extraction company incorporated in 2009, operating primarily in the United States. The company focuses on domestic uranium production using proven in-situ recovery (ISR) technology, which is environmentally responsible and cost-efficient. enCore owns and operates three of the ten licensed ISR Central Processing Plants (CPPs) in the U.S., all located in Texas, including the Rosita and Alta Mesa projects where uranium extraction commenced in 2023 and 2024 respectively. The company holds significant mineral resources compliant with SEC S-K 1300 standards across Texas, South Dakota, Wyoming, and New Mexico. enCore's business model includes uranium extraction, processing, and sales under multi-year contracts with major U.S. utilities. The company has a joint venture with Boss Energy Limited for the Alta Mesa Project and continues to optimize operations, manage costs, and rationalize its asset base. enCore is subject to competitive pressures from larger uranium producers and geopolitical risks affecting supply chains and market conditions. The company employs a workforce of over 250 individuals, including full-time employees and contractors, and emphasizes talent development and retention.

Brainstorm Cell Therapeutics Inc. focuses on developing and commercializing autologous adult stem cell therapies for neurodegenerative diseases such as ALS, progressive multiple sclerosis, and Alzheimer's disease. Its proprietary NurOwn® technology involves harvesting a patient’s own bone marrow-derived mesenchymal stem cells, differentiating them into neurotrophic factor secreting cells, and administering them intrathecally. The company has conducted late-stage clinical trials for NurOwn® in ALS and holds Fast Track and Orphan Drug designations from the FDA. Manufacturing is conducted in Israel under GMP standards. The company’s stock trades on the OTCQB Venture Market following delisting from Nasdaq due to equity requirements. Brainstorm has not yet generated revenues and continues to incur operating losses, with liquidity constraints noted in recent financial disclosures.

20/20 Biolabs, Inc. is a U.S.-based diagnostics company specializing in AI-powered, laboratory-based blood tests aimed at early detection and prevention of cancers and chronic diseases. Its primary products are the OneTest for Cancer, a multi-cancer early detection test using protein tumor markers combined with AI algorithms, and OneTest for Longevity, which measures inflammatory biomarkers related to chronic disease risk. The company operates a CAP-accredited, CLIA-licensed laboratory in Gaithersburg, Maryland, and also offers a Clinical Laboratory Innovation Accelerator (CLIAx) service for overseas diagnostic startups. Legacy products include BioCheck, a field test kit for bioterror agent screening. The company has reagent supply agreements with Roche and Abbott and relies on a network of retail blood draw providers. Revenue is primarily derived from OneTest for Cancer, with smaller contributions from BioCheck and CLIAx. The company faces competition from other MCED providers, including ctDNA-based tests, and emphasizes affordability and early-stage detection sensitivity as key differentiators.

VASO Corp is a diversified healthcare company operating through three main segments: IT services via VasoTechnology, professional sales services through VasoHealthcare, and proprietary medical equipment manufacturing and sales via VasoMedical. The IT segment focuses on managed network infrastructure, transport, and security services, having divested its healthcare IT business in November 2025. The professional sales service segment acts as the exclusive sales representative for GE HealthCare Technologies' diagnostic imaging and ultrasound equipment in specific U.S. markets, supported by a large sales force and proprietary sales management tools. The equipment segment develops and markets cardiovascular diagnostic and therapeutic devices and software, including EECP therapy systems, ambulatory monitoring devices, and cloud-based analysis software, selling directly in the U.S. and China and through distributors internationally. The company reported $89.1 million in revenue and $1.57 million net income for fiscal 2025, with a strong liquidity position. The GE HealthCare sales agreement is critical to the company's revenue and operating income. The company has a history of strategic divestitures and partnerships, including the sale of its healthcare IT unit and a management service agreement for EECP Global Corporation.

BluSky AI Inc. is a Nevada-based company specializing in AI compute infrastructure through modular data centers equipped with high-performance GPUs. The company targets the growing demand for AI and machine learning workloads by offering flexible, high-density computing solutions. BluSky AI relies on partnerships with modular data center providers and GPU manufacturers such as NVIDIA and AMD. The company integrates renewable energy sources into its operations, emphasizing sustainability. However, BluSky AI faces significant challenges including supply chain disruptions, competition from large hyperscale providers, limited access to powered land assets, and difficulties in talent acquisition. Financially, the company has incurred losses since inception, with liquidity constraints and substantial current liabilities exceeding current assets as of the end of 2025. Management has expressed concerns about the company's ability to continue as a going concern. The company’s stock trades on the OTC market and is classified as a penny stock, which may affect liquidity and investor access.

Spruce Power Holding Corporation is a U.S.-based company specializing in the ownership and operation of distributed solar energy assets, primarily residential home solar systems. It offers subscription-based services to homeowners under long-term contracts that generate recurring monthly payments. The company also sells solar renewable energy credits and provides portfolio management services through its Spruce Pro platform, servicing both its own and third-party solar assets. Spruce Power has grown through acquisitions, including several large portfolios acquired between 2022 and 2025, resulting in a diversified portfolio of approximately 84,000 home solar assets across 18 states. The company focuses on leveraging its platform to expand subscription-based distributed energy solutions, improve customer service, and increase shareholder value through predictable revenues and cash flows. It operates with in-house capabilities for billing, collections, customer support, and asset management. The company faces competition from vertically integrated solar companies, finance-focused entities, and regulated utilities. It is subject to various regulatory requirements and government incentives related to solar energy. Financially, Spruce Power reported net losses and has significant debt obligations, with liquidity and refinancing risks noted in its latest filings.

Voyager Acquisition Corp. operates as a SPAC with the primary purpose of acquiring or merging with a target company. It completed a business combination with Veraxa Biotech AG, which develops novel cancer therapies including bispecific antibody drug conjugates targeting solid tumors. The company’s shares and warrants are listed on the Nasdaq Global Market. The business combination agreement has been amended multiple times to adjust terms and support the transaction. Veraxa’s activities include showcasing therapies at major industry conventions and forming strategic alliances to advance its drug development programs.

Byrn, Inc., formerly known as Quture International, Inc. and Born, Inc., is a Nevada corporation originally formed in 2011 to develop healthcare knowledge solutions through medical software. The company was dormant for extended periods and underwent several ownership and structural changes. It later positioned itself as a holding company focused on digital, data-led solutions for retail supply chains and online transactions. As of the latest filings, Byrn is a dormant shell company with no active operations.

Iron Horse Acquisition II Corp. is a special purpose acquisition company (SPAC) incorporated initially in Delaware and later continued to the Cayman Islands. The company’s business purpose is to effect a merger or similar business combination with one or more target businesses. It completed its IPO in December 2025, raising gross proceeds of $230 million plus $5.7 million from private placements, with funds held in a Trust Account to be used for the business combination. The company has not commenced operations or generated revenues and currently incurs expenses related to being a public company and pursuing a business combination. The company’s financial position as of early 2026 shows liquidity coverage of current liabilities but management has noted substantial doubt about its ability to continue as a going concern without completing a business combination.

Lindsay Corporation is a manufacturer and marketer of irrigation systems and infrastructure products. Its Irrigation segment includes center pivot, lateral move, and hose reel irrigation systems, along with advanced technology solutions such as GPS positioning, variable rate irrigation, and IIoT capabilities. The Infrastructure segment produces moveable barriers, specialty barriers, crash cushions, end terminals, and road safety equipment. The company operates without any single customer concentration above 10%. It recognizes revenue both at a point in time and over time, with contract liabilities reflecting advance payments from customers. The company maintains a share repurchase program and reports detailed financial results quarterly.

Navan, Inc. is a global AI-powered business travel and expense platform designed to unify users, customers, and suppliers on a single system. The platform integrates travel booking, corporate payments, expense management, meetings and events planning, VIP services, and bleisure travel. Navan's proprietary AI framework, Navan Cognition, powers virtual agents that automate complex tasks across the travel lifecycle, enhancing user experience and operational efficiency. The Navan Cloud infrastructure aggregates global real-time travel inventory through direct supplier relationships, API integrations, and partnerships, providing extensive access to airlines and lodging properties worldwide. The platform also offers deep enterprise integrations with HR, ERP, and financial systems to streamline compliance and reconciliation. Navan targets both managed and unmanaged travel markets, focusing on cost savings, policy adherence, and user engagement to drive growth [S1].

Caleres Inc is a footwear company operating two main segments: Famous Footwear, a retail chain with over 800 stores in North America offering branded and company-owned footwear products, and Brand Portfolio, which designs, sources, manufactures, and markets a range of owned and licensed footwear brands. The company sells through retail stores, e-commerce platforms, wholesale customers including major retailers, and licensing agreements. Caleres sources most of its footwear from independent manufacturers primarily in Asia, while maintaining some owned manufacturing facilities in North America for premium brands. The company has implemented strategic initiatives to optimize inventory and product offerings and operates a customer loyalty program. Financially, Caleres reported a net loss for fiscal 2025 with modest liquidity ratios. Recent news indicates ongoing operational developments and dividend payments.

CISO Global, Inc. is a cybersecurity company listed on NASDAQ under the ticker CISO. It develops and markets cybersecurity solutions including AI-powered penetration testing tools and cloud security products. The company targets multiple market segments such as dental clinics, small and medium businesses, professional employer organizations (PEOs), and financial management firms. It has formed strategic partnerships to expand its CyberSimple® product powered by CHECKLIGHT®, aiming to address a multi-billion dollar market opportunity. The company has demonstrated commitment to cybersecurity standards through SOC 2 Type II, CMMC, and DIBCAC compliance. Leadership includes CEO David G. Jemmett, with a board comprising independent directors with financial and industry expertise. Financially, the company reported a net loss for fiscal year 2025 and exhibits limited short-term liquidity based on SEC filings.

ChargePoint Holdings Inc is a provider of electric vehicle charging technology solutions, operating primarily in North America and Europe. The company offers a broad range of Networked Charging Systems hardware, including Level 2 AC chargers for commercial, fleet, and residential use, and Level 3 DC fast chargers for commercial and fleet applications. ChargePoint’s software platform includes the ChargePoint Management System (CMS) and e-Mobility Service Provider (eMSP) services, enabling customers to manage charging infrastructure, driver access, payments, and energy optimization. ChargePoint serves three main customer groups: Charge Point Operators (CPOs), e-Mobility Service Providers, and EV drivers. The company uses a two-tiered indirect sales model through distributors and resellers and has strategic partnerships, such as with Eaton Corporation, to enhance product development and distribution. ChargePoint’s business model generates revenue from hardware sales, software subscriptions, extended warranties, and professional services. The company reported a net loss for fiscal 2026 and maintains liquidity with cash and equivalents of $141.6 million as of January 31, 2026. ChargePoint operates in a competitive and rapidly evolving EV charging market with risks related to growth management, supply chain, competition, and financial leverage.

QUHUO Ltd is a China-based gig economy platform focusing on community-centered services. It operates a large, flexible, and standardized workforce platform providing tech-enabled, end-to-end operational solutions primarily to consumer service businesses. Its main service categories include on-demand delivery solutions, mobility service solutions (including ride-hailing and vehicle export), housekeeping, and accommodation solutions. The company generates most of its revenue from service fees paid by industry customers, with additional income from rental fees under car leasing agreements with drivers. QUHUO faces competition from labor outsourcing companies, service suppliers, and online workforce marketplaces in a fragmented market. The company invests in technology infrastructure, notably its Quhuo+ platform, and talent to enhance operational efficiency and support expansion into new geographical markets and industries. Seasonality affects demand, with higher activity during inclement weather and holidays and workforce shortages during Chinese New Year. Customer concentration is notable, with the top three customers accounting for a significant portion of revenues. The company has pursued strategic acquisitions and partnerships, including a recent alliance with Panasonic Navinfo, to strengthen its market position and diversify its offerings. [S1][S2][N2]

MMTec, Inc. is a holding company incorporated in the British Virgin Islands with principal operations conducted through its PRC-based operating entity and subsidiaries in Hong Kong and the US. The company provides comprehensive internet-based technology services and solutions to Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms globally. Its business model centers on integrated technology platforms supporting securities trading, private fund investment management, and client trading systems across mobile and PC. Clients include PRC financial institutions and Hong Kong broker-dealers who may white label MMTEC's trading interface or select modular functionalities. The company also offers fund establishment, issuance, custody, transaction, and settlement services, focusing on small and medium-sized private equity funds. MMTEC has expanded into financial advisory and investment banking services targeting PRC-based SMEs accessing US capital markets. The company briefly entered the insurance agency industry in 2023 but divested that business by year-end. MMTEC emphasizes cloud technology, user-centered product development, and localized Chinese language support to lower technology access thresholds and improve user experience. As of December 31, 2025, MMTEC reported $807,500 in revenue and a net loss of $56.1 million, with strong liquidity and improved working capital. The company employs 31 full-time staff and maintains operations in Hong Kong, Beijing, Shenzhen, and New York. Recent developments include restructuring of subsidiaries and regaining Nasdaq compliance on bid price rules.

IRIDEX Corporation develops and commercializes laser-based medical devices for treating sight-threatening eye conditions such as glaucoma and retinal diseases. Its proprietary MicroPulse® and Endpoint Management™ technologies enable low-energy, tissue-sparing laser therapies offered alongside standard continuous-wave laser treatments. The company’s product portfolio includes glaucoma laser systems (Cyclo G6®), medical retina lasers (IQ 532®, IQ 577®, PASCAL System), and surgical retina lasers (OcuLight® TX and SLx). Revenue is generated from sales of laser consoles, consumable single-use probes, and service contracts. Sales are primarily direct in the US and Germany, with international sales through distributors. IRIDEX’s products are used globally by ophthalmologists in hospitals, surgical centers, and clinics. The company’s business model includes recurring revenue streams from consumables and service contracts, supporting ongoing customer relationships.

Trilogy Metals Inc. is primarily engaged in the exploration and development of mineral properties in Alaska, specifically the Upper Kobuk Mineral Projects (UKMP). These projects are held through Ambler Metals, a joint venture with South32 owning 50%. The company has no history of production or mining revenue and relies on external financing and strategic partnerships to fund its activities. The UKMP projects are located in a remote area requiring significant infrastructure development, including road access via the proposed Ambler Access Project (AAP), which faces permitting and legal challenges. The company’s success depends on the progress of exploration, development, and the cooperation of its joint venture partner. Metal price fluctuations and operational risks inherent to mining add to the uncertainties. Trilogy Metals reported a net loss and maintains liquidity with cash and current assets exceeding current liabilities as of early 2026.

Regional Health Properties, Inc. operates as a healthcare company owning and managing healthcare real estate and operating healthcare facilities and services. The company’s business model integrates ownership of skilled nursing and senior housing facilities with direct operation of these facilities and related healthcare services, including pharmacy operations acquired through the merger with SunLink Health Systems. The company’s portfolio includes owned and leased skilled nursing facilities and senior housing communities primarily located in the Southeastern United States. Regional Health’s strategy focuses on acquiring underperforming healthcare facilities and improving their operational and financial performance through active management, clinical oversight, and targeted capital investment. The company operates through three segments: Healthcare Services, Pharmacy Services, and Real Estate. Financially, the company reported $53.16 million in revenue for fiscal 2025 and maintains liquidity with $3 million in cash and equivalents as of December 31, 2025. The company has completed multiple repurchases of its Series B preferred shares and continues to integrate its expanded operations post-merger.

BBB FOODS INC, operating under the brand Tiendas 3B, is a pioneer and leader in the grocery hard discount retail sector in Mexico. The company focuses on delivering value to budget-conscious consumers by offering quality products at affordable prices, encapsulated in its name meaning 'Good, Nice and Affordable.' Since its NYSE listing in February 2024, BBB FOODS has been recognized for rapid sales and store growth. The company reported fiscal year 2025 revenue of approximately 78.15 billion MXN but incurred a net loss of about 2.84 billion MXN. Liquidity metrics as of year-end 2025 show a current ratio below 1, indicating current liabilities exceed current assets. BBB FOODS continues to expand its footprint in the Mexican retail market while managing operational challenges.

iTonic Holdings Ltd is a Cayman Islands-based company with principal offices in Beijing, China. It files annual reports on Form 20-F with the SEC and has recently undergone a corporate name change from Pheton Holdings Ltd. The company completed a significant share acquisition in late 2025 and is engaged in raising capital through private placements. Financial disclosures indicate modest revenue with a net loss for the fiscal year ended December 31, 2025. The company maintains strong liquidity ratios as of the end of 2025.

VSee Health, Inc. delivers telehealth solutions primarily through its wholly-owned subsidiary VSee Lab, which offers a no-code configurable telehealth platform for hospitals and healthcare enterprises in the U.S. The platform includes software building blocks for virtual visits, scheduling, patient intake, compliance, team coordination, remote exams, patient monitoring, payments, and analytics. It integrates with major EMRs like EPIC and Cerner and complies with HIPAA, SOC2, and GDPR standards. The company also operates iDoc, providing telemedicine physician staffing for intensive care units and specialty care, serving a range of customers from large hospitals to federal prisons. VSee Health addresses healthcare challenges such as clinician shortages and patient engagement by empowering clinicians to configure workflows independently and providing AI-enhanced nursing solutions. The company employs a direct sales force supported by marketing and customer success teams and faces competition from EMR telehealth tools, established telehealth platforms, and large technology companies developing virtual care solutions.

Founded in 2005 and headquartered in Illinois, LanzaTech Global, Inc. develops and licenses proprietary gas fermentation technology that transforms waste carbon gases into valuable fuels, chemicals, and materials. The company’s platform uses specialized microbes to convert diverse feedstocks including industrial off-gases, gasified municipal solid waste, biomass, and reformed landfill gas into ethanol and derivatives. LanzaTech’s technology supports circular carbon economy goals by enabling industrial emitters to monetize waste carbon and reduce emissions. The company has commercialized its technology at six plants globally and collaborates with industry leaders to expand applications including sustainable aviation fuel (SAF) production through its majority-owned spinoff, LanzaJet. LanzaTech generates revenue primarily through licensing fees, microbe supply, software support, and co-development projects. The company holds a robust intellectual property portfolio and operates in a competitive landscape with companies possessing greater resources but lacking LanzaTech’s integrated platform at scale.

Bimergen Energy Corporation, formerly known as Bitech Technologies Corporation, is a Delaware-incorporated renewable energy project developer specializing in utility-scale Battery Energy Storage Systems (BESS) and solar energy projects. The company’s strategic objective is to develop, commercialize, and operate a diversified portfolio of BESS and solar projects across key U.S. Independent System Operator (ISO) regions including ERCOT, WECC, PJM, and MISO. Bimergen acquired Emergen Energy LLC in April 2024, gaining a portfolio of 23 BESS projects with an estimated 1.965 GW storage capacity and 13 solar projects with 1.640 GW generation capacity. The company is in the mid-stage of development, actively advancing approximately 2 GW of BESS projects. Its business model focuses on grid balancing by storing excess renewable energy during low demand and dispatching it during peak demand, providing energy arbitrage and ancillary grid services such as frequency regulation and voltage support. Revenue generation is planned primarily through long-term tolling agreements with institutional energy traders, offering guaranteed floor payments and upside profit sharing, although no such agreements have been finalized. If favorable contracts are not secured, Bimergen intends to operate projects on a merchant power basis, exposing it to market price volatility. The company has formed a joint venture with battery supplier RelyEZ, which committed up to $50 million in funding. Bimergen completed a $13.6 million public offering in February 2026 to fund project development and working capital. As of December 31, 2025, the company had not commenced commercial operations or generated revenue and had limited liquidity with a current ratio of 0.42. The company is progressing projects toward construction readiness, awarding contracts for Texas-based BESS projects, and engaging in investor communications to support its $2 billion growth strategy.

Velo3D, Inc. develops and manufactures advanced metal additive manufacturing systems and provides production and engineering services enabling customers to produce high-value metal parts at scale. Its business model combines equipment sales of the Sapphire family of 3D printers and associated software with production services through Rapid Production Solutions (RPS) and Expert Services. The company’s proprietary technology platform integrates print preparation software (Flow), metal 3D printers (Sapphire series), quality assurance software (Assure), and the Intelligent Fusion manufacturing process. Velo3D targets aerospace, defense, energy, automotive, semiconductor, and industrial markets, focusing on customers requiring complex geometries and scalable production. The company operates an asset-light manufacturing model, relying on third-party suppliers for components and final assembly internally. Customers include OEMs and contract manufacturers, with a significant portion of revenue derived from defense-related programs. Velo3D holds a strong intellectual property portfolio and pursues a land-and-expand growth strategy through direct sales and distribution partnerships globally [S1].

Direct Digital Holdings, Inc. is a digital advertising company that provides marketing and advertising services through a technology platform. The company’s operations include a subsidiary, Direct Digital Holdings, LLC, which supports its financial and operational activities. The business faces challenges common to the digital advertising industry, including adapting to changes in tracking technologies and data privacy regulations. Financially, the company has reported significant losses and liquidity constraints as of the end of 2025. The company undertook a reverse stock split in early 2026 to adjust its share structure. Recent operational highlights include recognition for marketing campaigns by its subsidiary Orange 142.

AngioDynamics Inc develops, manufactures, and sells a broad range of medical, surgical, and diagnostic devices primarily for vascular access, peripheral vascular disease treatment, oncology, and surgical applications. Its products are designed for minimally invasive, image-guided procedures and include disposable and temporarily implanted devices. The company operates mainly in the U.S. through a direct sales force and internationally via distributors. Its product portfolio is divided into Med Tech, including platforms like Auryon, thrombus management, and NanoKnife, and Med Device, which includes Core, Venous, Ports, Microwave, and Oncology products. The company focuses on innovation, regulatory pathway expansion, and customer-centric sales to drive growth. It faces macroeconomic challenges such as supply chain issues, inflation, tariffs, and labor shortages, which impact manufacturing and costs.

STARRY SEA ACQUISITION CORP is a Cayman Islands exempted blank check company formed to complete a merger, share exchange, asset acquisition, or similar business combination. It has not generated revenue and focuses on identifying a target business with strong financial visibility, defensible market position, and growth potential. The company completed its IPO in August 2025, raising $57.5 million placed in a trust account. It intends to leverage its management team's expertise and networks to identify and execute a business combination. The company has no operating segments and currently incurs formation and operating costs. It has no long-term debt and maintains liquidity primarily through trust account funds and cash on hand.

CN Healthy Food Tech Group Corp. operates as a holding company with no direct operations, managing its core business through wholly-owned subsidiaries in China. These subsidiaries develop, manufacture, and market premium health foods that integrate AI-powered biotechnology with traditional Chinese medicine principles. The company’s product portfolio includes grain-based health foods and supplements such as Shangshan Suyang Porridge, plant-based essential oils, collagen peptide prebiotics, and gummy supplements. The company relies on OEM suppliers for production and employs a marketing strategy that combines digital and offline channels to attract and retain distributors and customers. The company completed a business combination with Iron Horse Acquisition Corp. in September 2025 and began trading on Nasdaq in October 2025 under ticker UCFI. However, trading has been halted since October 1, 2025, due to the China Securities Regulatory Commission’s ongoing review of the company’s U.S. listing. The company’s financials as of September 30, 2025, show revenue of $7.9 million, net income of $3.3 million, and a strong liquidity position with cash and equivalents of $37.2 million and a current ratio of 1.21. The company faces regulatory uncertainties related to Chinese government approvals for overseas listings and operational risks associated with doing business in China, including compliance with evolving laws and regulations.

KULR Technology Group, Inc. designs and manufactures advanced battery systems targeting autonomous platforms, digital infrastructure, e-mobility, and space applications. The company addresses critical challenges in electrification, focusing on thermal management and safety to enhance system reliability. KULR operates a fully integrated battery design and production facility in Houston, Texas, enabling rapid development and scalable manufacturing of high-performance battery packs. Additionally, KULR develops proprietary vibration reduction technology (KULR VIBE) applicable across various high-speed and rotor-driven systems. In 2025, KULR expanded its business model to include bitcoin treasury management and mining operations, acquiring substantial bitcoin holdings and deploying mining machines under lease agreements. The company generates revenue from product sales, contract services, grant awards, and digital asset mining, with ongoing exploration of licensing opportunities for its technologies.

Infobird Co., Ltd operates primarily in the digital advertising and marketing campaign sector, focusing on the maternal and infant vertical market in Mainland China. The company transitioned away from business integration services by 2025, concentrating its operations on digital marketing. Revenue increased significantly in 2025 following an acquisition in late 2024, with digital advertising services accounting for all reported revenues. The company holds intellectual property rights including patents and software copyrights, which support its technology offerings. Infobird faces high customer concentration risk and foreign exchange exposure due to RMB-denominated operations. The company maintains moderate liquidity with a current ratio near 2.0 as of the end of 2025.